ZBH
Zimmer Biomet Holdings, Inc. · Healthcare · Medical - Devices
Momentum-inputs (vergelijkbare managers):
breedte van houders -13.0% ·
aandelenstroom +5.2% ·
netto nieuwe posities -15.0%
· formule
Geconcentreerde accumulatie: stijgende aandelen bij minder houders
Alle eigendomscijfers: uitsluitend gevolgde 13F-managers, posities in gewone aandelen, rapportageperiode Q2 2025
| Kwartaal | Houders | Δ | Aandelen | Gerapporteerde waarde | Nieuw | Uitstappen |
|---|---|---|---|---|---|---|
| Q2 2026 | 156 | +1 | 159.53M | $13.74B | +8 | −8 |
| Q1 2026 | 159 | -2 | 157.26M | $14.21B | +8 | −11 |
| Q4 2025 | 160 | -1 | 174.74M | $15.72B | +3 | −3 |
| Q3 2025 | 25 | +3 | 107.43M | $10.58B | +3 | −1 |
| Q2 2025 | 20 | -3 | 103.64M | $9.45B | +2 | −5 |
| Q1 2025 | 20 | +3 | 59.00M | $6.68B | +3 | n/a |
| Q4 2024 | 17 | 0 | 58.85M | $6.22B | +1 | −1 |
| Q3 2024 | 16 | -2 | 46.04M | $4.97B | n/a | −2 |
| Q2 2024 | 18 | n/a | 44.34M | $4.81B | n/a | n/a |
| # | Manager | Aandelen | Δ aandelen | Waarde | Hun gewicht | Gehouden | ||
|---|---|---|---|---|---|---|---|---|
| 1 | The Vanguard Group ✦ (passief) | 23.25M | n/a | $2.12B | 0.0% | n/c | 1 | SEC ↗ ×6 |
| 2 | Dodge & Cox ✦ | 22.10M | +12.9% | $2.02B | 1.1% | ▲ Add | 5 | SEC ↗ |
| 3 | BlackRock ✦ (passief) | 16.12M | n/a | $1.47B | 0.0% | n/c | 1 | SEC ↗ ×21 |
| 4 | T. Rowe Price ✦ | 14.80M | +2.4% | $1.35B | 0.2% | ▲ Add | 5 | SEC ↗ ×2 |
| 5 | State Street Global Advisors ✦ (passief) | 8.75M | -0.1% | $800.00M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 6 | Geode Capital Management ✦ (passief) | 5.12M | +1.4% | $465.48M | 0.0% | ▲ Add | 5 | SEC ↗ ×2 |
| 7 | PRIMECAP Management ✦ | 4.71M | +0.6% | $429.67M | 0.3% | ▲ Add | 5 | SEC ↗ |
| 8 | Harris Associates (Oakmark) ✦ | 3.73M | Nieuw | $340.40M | 0.6% | New | 1 | SEC ↗ ×2 |
| 9 | Norges Bank ✦ (passief) | 2.48M | +16.4% | $225.87M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 10 | AQR Capital Management ✦ | 1.30M | +276.6% | $118.63M | 0.1% | ▲ Add | 5 | SEC ↗ ×6 |
| 11 | Arrowstreet Capital ✦ | 514.92K | +8.9% | $46.97M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 12 | Marshall Wace ✦ | 249.48K | -28.3% | $22.76M | 0.0% | ▼ Trim | 2 | SEC ↗ ×3 |
| 13 | GAMCO Investors ✦ | 245.96K | +22.5% | $22.43M | 0.2% | ▲ Add | 5 | SEC ↗ |
| 14 | Fidelity (FMR) ✦ | 120.36K | n/a | $10.98M | 0.0% | n/c | 1 | SEC ↗ ×3 |
| 15 | Gotham Asset Management ✦ | 88.97K | +301.9% | $8.11M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 16 | Wellington Management ✦ | 37.95K | +2.9% | $3.46M | 0.0% | ▲ Add | 5 | SEC ↗ ×2 |
| 17 | Millennium Management ✦ | 12.11K | -98.2% | $1.10M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 18 | Bridgewater Associates ✦ | 6.56K | -23.0% | $598,429 | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 19 | Fisher Asset Management ✦ | 4.49K | -1.8% | $409,540 | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 20 | Capital World Investors ✦ | 3.08K | Nieuw | $281,292 | 0.0% | New | 1 | SEC ↗ |
"Hun weging" = het aandeel van de positie in de gerapporteerde 13F-aandelenwaarde van die manager: de overtuigingsmaatstaf. ✦ = gecureerde manager.
Nieuwe kopers
| Harris Associates (Oakmark) | $340.40M | 0.6% |
| Capital World Investors | $281,292 | 0.0% |
Verlaten
| Citadel Advisors | $231.18M | was 0.2% |
| Point72 Asset Management | $9.94M | was 0.0% |
| D. E. Shaw & Co. | $5.23M | was 0.0% |
| Adage Capital Partners | $4.21M | was 0.0% |
| Two Sigma Investments | $3.44M | was 0.0% |
Volledige marktcontext: over ALLE 13F-indieners (SEC gestructureerde data, Q1 2026): 908 houders, 191.49M aandelen, $15.84B gerapporteerd. Dit betreft een andere, oudere periode dan de bovenstaande cijfers van het gevolgde universum; beide worden nooit gecombineerd.
Wat de gevolgde houders van dit effect het vaakst nog meer bezitten: aantallen gedeeld eigendom, geen fundamentele relaties.
Open-market aankopen (P)
Geen open-market insider-aankopen in ons dekkingsvenster.
Open-market verkopen (S)
Officer · 5.69K aand · $528,978
Officer · 3.00K aand · $295,050
Toekenningen, uitoefeningen en belastinginhoudingen worden hier nooit meegeteld als aankopen of verkopen. Methodologie